IMPURITIES AVAILABLE FOR 'Imatinib Mesylate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Imatinib Mesylate. Imatinib mesylate is a targeted anticancer drug primarily used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It is a tyrosine kinase inhibitor that works by blocking the BCR-ABL fusion protein, a key driver in CML, as well as other abnormal kinases involved in cancer cell growth. Imatinib is taken orally and has significantly improved survival rates for patients with CML. It selectively inhibits cancer cell proliferation with less harm to normal cells. Common side effects include nausea, fatigue, muscle cramps, and fluid retention. Regular monitoring is required to assess response and manage toxicity. Buy high quality Imatinib Mesylate from Omsynth Lifesciences.